Home Next-Generation Approaches To Statistical Significance

Next-Generation Approaches To Statistical Significance

Christian K Schneider | Head of Biopharma Excellence / Chief Medical Officer

The panel considered the potential for supplementary data sets – such as pharmacodynamic read-outs, histological evidence and historical controls – in enabling regulators to reach robust decisions.

Go Back

Start a conversation today

Socials:

First Name*

Last Name*

Telephone

Country*

State*

Company Name*

Email*

Your message

Please check this box if you wish to receive information from Cencora and its affiliates

By submitting this form, you understand that Cencora may process your data as described in the Cencora Privacy Policy